Landscapes / Companies
AbelZeta Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials
Trials
4 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Gene therapy substances |
Phase 2 | 31 Mar 2027Phase 1/2 trial completes | |||
| How it works | A gene therapy | ||||
| Next date | 31 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory Large B-Cell Lymphoma, Large B Cell Lymphoma and 10 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE) and 16 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021